Study: Proprietary Nutrient Mixture Inhibits Renal Cancer Spread
PrimeNewswire, Inc.
Public Affairs Newsline
Source: Dr. Rath Education Services USA, BV
Specific Combination of Lysine, Proline, Arginine, Ascorbic Acid, and Green Tea Extract Stops the Ability of Kidney Cancer Cells to Spread
SANTA CLARA, Calif., Dec. 4, 2006 (PRIME NEWSWIRE) (PRIMEZONE) -- The Dr. Rath Research Institute, a leader in developing a natural means of controlling the spread of cancer through nutrient synergy, has published another study confirming the effectiveness of this approach in kidney cancer. The research further supporting the effectiveness of natural compounds applied in synergy to control cancer has recently been published in the medical journal, Oncology Reports 16: 943-947, 2006.
The study, entitled "Anticancer effect of lysine, proline, arginine, ascorbic acid, and green tea extract on human renal adenocarcinoma line 786-0," investigates the antimetastatic effects of this specific nutrient mixture on cancer cell proliferation, modulation of MMP-2 and -9 secretion, and cancer cell invasive potential.
"Our studies have shown that by providing key combinations of specific nutrients to the body we can practically achieve the total inhibition of MMP-2 and -9 secretion, cancer cell proliferation, and cancer cell invasion in renal tissue," said Research Director Dr. Aleksandra Niedzwiecki. "These results further confirm the effectiveness of Dr. Rath's approach to the natural control of cancer. Our selected nutrient combination works by strengthening and stabilizing the connective tissue surrounding all cancer cells, thereby helping to prevent their spread in the body and their metastasizing to other organs."
Currently, there are no conventional medical treatments to curb metastasis. This is important because 90% of cancer deaths are actually caused by the spread of cancer from the original tumor to other areas of the body, such as organs and other tissues -- not the original tumor.
The more successful a cancer is at spreading through the body, the less likely the patient is to survive. Traditional methods of treating Renal Cell Carcinoma, such as surgery, radiation therapy, chemotherapy, and hormone therapy have been largely unsuccessful at controlling the progression of cancer because they do not address the most lethal aspect of cancer: metastasis. Instead, these methods may actually promote tumor progression by impairing the body's immune system, not to mention their other severely toxic side effects.
The American Cancer Society estimates that there were approximately 36,160 new cases of kidney cancer in 2005 alone. Of these cases, about 50% are localized to the kidney, while the other 50% is divided between cancer spread to nearby tissue (25%) and cancer spread to distant tissue (25%). The associated 5-year survival rate for metastasized cancer is only about 9%.
Dr. Niedzwiecki concluded, "Our research has consistently proven that nutrient synergy can be a powerful, safe, and effective method for the inhibition of the key mechanisms of cancer: metastasis, angiogenesis, tumor growth, and the instigation of apoptosis (natural cell death). Through the application of our research in nutrient synergy, we can effectively put a stop to the spread of one of the world's most deadly diseases by enhancing natural body mechanisms in a safe and effective way."
About the Dr. Rath Research Institute
Scientists at the Dr. Rath Research Institute conduct cutting-edge research in natural health based on Dr. Rath's scientific discoveries in the area of cardiovascular disease, cancer, and diseases of the immune system. Their research focuses on the understanding of the critical role of essential nutrients in restoring and maintaining health at the deepest and most important level in the human body -- the cellular level.
For more information, please visit www.drrathresearch.org
CONTACT: Dr. Rath Education Services USA, BV
Bryan Tallman
(408) 567-5059